Literature DB >> 1950621

Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.

S Robinson1, P Rosca, R Durst, U Shai, C Ghinea, U Schmidt, I Nir.   

Abstract

Conflicting results on changes of the diurnal melatonin rhythms of patients with affective disorders have been reported in the literature. The heterogeneous data may derive from the great discrepancy in the diagnostic criteria of different authors. A study of 12 schizoaffective and chronic schizophrenic psychotic patients found a constant pattern of an obliterated nocturnal melatonin rise only in the latter group. The presence or absence of the nocturnal melatonin rise was determined in drug-free hospitalized patients and remained unchanged despite 2 months of drug treatment including large doses of neuroleptics. This finding, when confirmed in a larger number of patients, could possibly serve as a marker for the type of mental disorder, drug to be applied and response expected.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1950621     DOI: 10.1111/j.1600-0447.1991.tb03133.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  9 in total

1.  Brief report: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism.

Authors:  I Nir; D Meir; N Zilber; H Knobler; J Hadjez; Y Lerner
Journal:  J Autism Dev Disord       Date:  1995-12

Review 2.  Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.

Authors:  D B Boivin
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

3.  Evidence for an association of serum melatonin concentrations with recognition and circadian preferences in patients with schizophrenia.

Authors:  Cigdem Sahbaz; Omer Faruk Özer; Ayse Kurtulmus; Ismet Kırpınar; Fikrettin Sahin; Sinan Guloksuz
Journal:  Metab Brain Dis       Date:  2019-02-13       Impact factor: 3.584

4.  Association of polymorphism in the promoter of the melatonin receptor 1A gene with schizophrenia and with insomnia symptoms in schizophrenia patients.

Authors:  Hae Jeong Park; Jin Kyung Park; Su Kang Kim; Ah-Rang Cho; Jong Woo Kim; Sung-Vin Yim; Joo-Ho Chung
Journal:  J Mol Neurosci       Date:  2011-04-28       Impact factor: 3.444

5.  Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects.

Authors:  Stefan Cohrs; Kathrin Pohlmann; Zhenghua Guan; Wolfgang Jordan; Andreas Meier; Gerald Huether; Eckart Rüther; Andrea Rodenbeck
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

Review 6.  Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.

Authors:  F Waldhauser; B Ehrhart; E Förster
Journal:  Experientia       Date:  1993-08-15

7.  Effect of Haloperidol and Risperidone on Serum Melatonin and GAP-43 in Patients with Schizophrenia: A Prospective Cohort Study.

Authors:  Rituparna Maiti; Biswa Ranjan Mishra; Monalisa Jena; Archana Mishra; Santanu Nath
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-02-28       Impact factor: 2.582

8.  Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven review.

Authors:  Rébecca Robillard; Naomi L Rogers; Bradley G Whitwell; Tim Lambert
Journal:  Clin Psychopharmacol Neurosci       Date:  2012-04-30       Impact factor: 2.582

Review 9.  Role of melatonin in schizophrenia.

Authors:  Armando L Morera-Fumero; Pedro Abreu-Gonzalez
Journal:  Int J Mol Sci       Date:  2013-04-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.